Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03874065 · ClinicalTrials.gov registry record
Medical Data Collection in the Formation of Precision Oncology Registry
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 2,885
- Enrollment target
NCT03874065 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 2,885 participants.
The verdict
NCT03874065 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 2,885 participants
- Enrollment target
Study Summary
In efforts to develop an aggregation point for patient clinical data and data related to DNA sequencing in the Comprehensive Cancer Center, this registry will be developed to provide a comprehensive data store. The goal of the registry will be to collect information on the Cancer Center population undergoing next generation DNA sequencing (NGS) on their tumors or liquid biopsies.
Interventions
- OTHER Medical Chart Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,885 participants |
| Start Date | 2019-05-17 |
| Est. Completion | 2024-01-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03874065
The ClinicalTrials.gov registry entry for NCT03874065 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2,885 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medical Chart Review is the first listed.
NCT03874065 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03874065 about?
NCT03874065 is a clinical study titled "Medical Data Collection in the Formation of Precision Oncology Registry". In efforts to develop an aggregation point for patient clinical data and data related to DNA sequencing in the Comprehensive Cancer Center, this registry will be developed to provide a comprehensive data store. The goal of the registry will be to collect information on the Cancer Center population u...
What is the current status of trial NCT03874065?
This trial is currently terminated. The enrollment target is 2,885 participants. The study started on 2019-05-17. Estimated completion is 2024-01-11.
What interventions are being tested in trial NCT03874065?
The interventions under investigation include: Medical Chart Review (OTHER).
Who is sponsoring clinical trial NCT03874065?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.